Caina Technology Co., Ltd. (SHE:301122)

Market Cap	3.03B +18.3%
Revenue (ttm)	425.33M +21.5%
Net Income	11.05M -69.1%
EPS	0.10 -65.2%
Shares Out	122.25M
PE Ratio	247.05
Forward PE	34.89
Dividend	0.04 (0.16%)
Ex-Dividend Date	Jun 9, 2026

Volume	5,353,954
Open	24.75
Previous Close	24.77
Day's Range	24.50 - 27.30
52-Week Range	19.46 - 35.99
Beta	0.85
Analysts	Buy
Price Target	36.21 (+39.11%)
Earnings Date	Aug 28, 2026

About Caina Technology

Caina Technology Co., Ltd. engages in the research, development, production, and sale of plastic particles, needle holders, needle tubes, rubber plugs and other packaging materials. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina Technology Co., Ltd. was founded in 2004 and is based in Jiangyin, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,057
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301122

Financial Performance

In 2025, Caina Technology's revenue was 356.69 million, a decrease of -8.04% compared to the previous year's 387.89 million. Earnings were 5.62 million, a decrease of -89.41%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 18, 2026

Data Sources Report a data error